Researchers at the Institute for Research in Biomedicine, Barcelona, have recently designed a new tool to study rescue signaling pathways and cell apoptosis. Their development might help scientists to better understand the phenomenon of cells’ excessive accumulation of errors in ...

Researchers at the University of Florida have discovered an enzymatic switch that allows some cells to live and leaves nearby cells to die. These results may be a key discovery in the fight against Alzheimer’s disease. The researchers found an ...

The San Francisco based biopharmaceutical company Medivation has recently published results of its first pivotal clinical trial of Dimebon in Alzheimer’s disease. Dimebon, a drug formerly approved as an allergy treatment, demonstrated statistically significant improvement over placebo in memory, thinking, ...

Scientists from UCLA recently pinpointed a possible physical origin of Alzheimer’s disease. The amyloid-beta protein has long been known to clump in the brain and be involved in the progression of the disease. The UCLA team identified a loop in ...